Brain metabolic changes in major depressive disorder from pre- to post-treatment with paroxetine

Psychiatry Research - Neuroimaging

Volumn 91, Issue 3, 1999, Pages 127-139

  Brody, Arthur L ^a,b   Saxena, Sanjaya ^a   Silverman, Daniel H S ^a   Alborzian, Shervin ^d   Fairbanks, Lynn A ^a   Phelps, Michael E ^a   Huang, Sung Cheng ^a   Wu, Hsiao Ming ^a   Maidment, Karron ^a   Baxter Jr , Lewis R ^a,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Gtr Los Angeles VA Hlthcare System   (United States)

^c UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^d UAB Dept of Behavioral Neurobiology ^*

Author keywords

18F fluorodeoxyglucose positron emission tomography; Anterior cingulate gyrus; Depression; FDG PET; Treatment response prediction; Ventrolateral prefrontal cortex

Indexed keywords

FLUORODEOXYGLUCOSE F 18; PAROXETINE; SEROTONIN UPTAKE INHIBITOR;

ADULT; ANIMAL MODEL; ARTICLE; BRAIN METABOLISM; CINGULATE GYRUS; CLINICAL ARTICLE; CLINICAL TRIAL; DEPRESSION; DRUG MECHANISM; FEMALE; HUMAN; IMAGING; MALE; ORAL DRUG ADMINISTRATION; POSITRON EMISSION TOMOGRAPHY; PREDICTION; PREFRONTAL CORTEX; PRIORITY JOURNAL; TREATMENT OUTCOME;

ADULT; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; BLOOD GLUCOSE; BRAIN MAPPING; DEPRESSIVE DISORDER, MAJOR; DOSE-RESPONSE RELATIONSHIP, DRUG; ENERGY METABOLISM; FEMALE; FLUORODEOXYGLUCOSE F18; GYRUS CINGULI; HUMANS; MALE; MIDDLE AGED; PAROXETINE; PREFRONTAL CORTEX; PROGNOSIS; TOMOGRAPHY, EMISSION-COMPUTED; TREATMENT OUTCOME;

EID: 0032828572     PISSN: 09254927     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0925-4927(99)00034-7     Document Type: Article

References (47)

1. Alexander G.E., DeLong M.R., Strick P.L. Parallel organization of functionally segregated circuits linking basal ganglia and cortex. Annual Review of Neuroscience. 9:1986;357-381.
2. Alpert N.M., Berdichevsky D., Weise S., Tang J., Rauch S.L. Stereotactic transformation of PET scans by nonlinear least squares. Uemura K., Jones J., Lassen N.A., Kanno I. Quantification of Brain Function: Tracer Kinetics and Image Analysis in Brain PET. 1993;459-463 Elsevier Science Publishers, Amsterdam, The Netherlands.
3. Baxter L.R., Phelps M.E., Mazziotta J.C., Schwartz J.M., Gerner R.H., Selin C.E., Sumida R.M. Cerebral metabolic rates for glucose in mood disorders. Archives of General Psychiatry. 42:1985;441-447.
4. Baxter L.R., Schwartz J.M., Phelps M.E., Mazziotta J.C., Guze B.H., Selin C.E., Gerner R.H., Sumida R.M. Reduction of prefrontal cortex glucose metabolism common to three types of depression. Archives of General Psychiatry. 46:1989;243-250.
5. Baxter L.R., Schwartz J.M., Bergman K.S., Szuba M.P., Guze B.H., Mazziotta J.C., Alazraki A., Selin C.E., Ferng H.K., Munford P., Phelps M.E. Caudate glucose metabolic rate changes with both drug and behavior therapy for obsessive-compulsive disorder. Archives of General Psychiatry. 49:1992;681-689.
6. Bench C.J., Friston K.J., Brown R.G., Scott L.C., Frackowiak R.S., Dolan R.J. The anatomy of melancholia - focal abnormalities of cerebral blood flow in major depression. Psychological Medicine. 22:1992;607-615.
7. Biver F., Goldman S., Delvenne V., Luxen A., De Maertelaer V., Hubain P., Mendlewicz J., Lotstra F. Frontal and parietal metabolic disturbances in unipolar depression. Biological Psychiatry. 36:1994;381-388.
8. 18F]2-deoxyglucose in affective illness. Journal of Affective Disorders. 10:1986;137-152.
9. Buchsbaum M.S., Wu J., Siegel B.V., Hackett E., Trenary M., Abel L., Reynolds C. Effect of sertraline on regional metabolic rate in patients with affective disorder. Biological Psychiatry. 41:1997;15-22.
10. Cherry S.R., Dahlbom M., Hoffman E.J. 3D PET using a conventional multislice tomograph without septa. Journal of Computer Assisted Tomography. 15:1991;655-668.
11. Devinsky O., Morrell M.J., Vogt B.A. Contributions of the anterior cingulate cortex to behaviour. Brain. 118:1995;279-306.
12. Dolan R.J., Bench C.J., Liddle P.F., Friston K.J., Frith C.D., Grasby P.M., Frackowiak R.S. Dorsolateral prefrontal cortex dysfunction in the major psychoses; symptom or disease specificity? Journal of Neurology, Neurosurgery and Psychiatry. 56:1993;1290-1294.
13. Drevets W.C. Functional neuroimaging studies of depression: the anatomy of melancholia. Annual Review of Medicine. 49:1998;341-361.
14. Drevets W.C., Raichle M.E. Neuroanatomical circuits in depression: implications for treatment mechanisms. Psychopharmacology Bulletin. 28:1992;261-274.
15. Drevets W.C., Videen T.O., Price J.L., Preskorn S.H., Carmichael S.T., Raichle M.E. A functional anatomical study of unipolar depression. Journal of Neuroscience. 12:1992;3628-3641.
16. Drevets W.C., Price J.L., Simpson J.R., Todd R.D., Reich T., Vannier M., Raichle M.E. Subgenual prefrontal cortex abnormalities in mood disorders. Nature. 386:1997;824-827.
17. Endicott J., Spitzer R.L., Fleiss J.L., Cohen J. The Global Assessment Scale. A procedure for measuring overall severity of psychiatric disturbance. Archives of General Psychiatry. 33:1976;766-771.
18. Feighner J., Targum S.D., Bennett M.E., Roberts D.L., Kensler T.T., D'Amico M.F., Hardy S.A. A double-blind, placebo-controlled trial of nefazodone in the treatment of patients hospitalized for major depression. Journal of Clinical Psychiatry. 59:1998;246-253.
19. Friston K.J. Statistical parametric mapping: ontology and current issues. Journal of Cerebral Blood Flow and Metabolism. 15:1995;361-370.
20. Friston K., Frith C., Liddle P., Frackowiak R. Comparing functional (PET) images: the assessment of significant change. Journal of Cerebral Blood Flow and Metabolism. 11:1991;690-699.
21. Friston K.J., Ashburner J., Frith C.D., Poline J., Heather J.D., Frackowiak R.S.J. Spatial registration and normalisation of images. Human Brain Mapping. 2:1995;165-189.
22. Friston K.J., Holmes A.P., Worsley K.J., Poline J.P., Frith C.D., Frackowiak R.S.J. Statistical parametric maps in functional imaging: a general linear approach. Human Brain Mapping. 2:1995;189-210.
23. Hamilton M. Development of a rating scale for primary depressive illness. British Journal of Social Psychology. 6:1967;278-296.
24. Hamilton M. Diagnosis and rating of anxiety. British Journal of Psychiatry. 3:1969;76-79.
25. Insel T.R. Toward a neuroanatomy of obsessive-compulsive disorder. Archives of General Psychiatry. 49:1992;739-744.
26. Kennedy S.H., Javanmard M., Vaccarino F.J. A review of functional neuroimaging in mood disorders: positron emission tomography and depression. Canadian Journal of Psychiatry. 42:1997;467-475.
27. 18F]FDG-PET study. Abstract 484.15 Annual Meeting of the Society for Neuroscience.
28. Ketter T.A., George M.S., Kimbrell T.A., Benson B.E., Post R.M. Functional brain imaging, limbic function and affective disorders. Neuroscientist. 2:1996;55-65.
29. Lin K.P., Huang S.C., Baxter L., Phelps M.E. A general technique for inter-study registration of multi-function registration of multi-function and multimodality images. IEEE Transactions in Nuclear Science. 41:1994;2850-2855.
30. 18F]-2-fluoro-2-deoxy-D-glucose method in resting, healthy human subjects. European Journal of Nuclear Medicine. 16:1990;267-273.
31. Mayberg H.S., Lewis P.J., Regenold W., Wagner H.N. Jr. Paralimbic hypoperfusion in unipolar depression. Journal of Nuclear Medicine. 35:1994;929-934.
32. Mayberg H.S., Brannan S.K., Mahurin R.K., Jerabek P.A., Brickman J.S., Tekell J.L., Silva J.A., McGinnis S., Glass T.G., Martin C.C., Fox P.T. Cingulate function in depression: a potential predictor of treatment response. Neuroreport. 8:1997;1057-1061.
33. Mayberg H.S., Liotti M., Brannan S.K., McGinnis S., Mahurin R.K., Jerabek P.A., Silva J.A., Tekell J.L., Martin C.C., Lancaster J.L., Fox P.T. Reciprocal limbic-cortical function and negative mood: converging PET findings in depression and normal sadness. American Journal of Psychiatry. 156:1999;675-682.
34. Mazziotta J.C., Phelps M.E., Meadors A.K., Ricci A., Winter J., Bentson J.R. Anatomical localization schemes for use in positron computed tomography using a specially designed headholder. Journal of Computer Assisted Tomography. 6:1982;848-853.
35. Nadeau S.E., Crosson B. A guide to functional imaging of cognitive processes. Neuropsychiatry, Neuropsychology and Behavioral Neurology. 8:1995;143-162.
36. Nobler M.S., Sackheim H.A., Prohovnik I., Moeller J.R., Mukherjee S., Schnur D.B., Prudic J., Devanand D.P. Regional cerebral blood flow in mood disorders. III: Treatment and clinical response. Archives of General Psychiatry. 51:1994;884-897.
37. Parent A., Hazrati L.-N. Functional anatomy of the basal ganglia. I. The cortico-basal ganglia-thalamo-cortical loop. Brain Research: Brain Research Reviews. 20:1995;91-127.
38. Parent A, Hazrati L.-N. Functional anatomy of the basal ganglia. II. The place of the subthalamic nucleus and external pallidum in basal ganglia circuitry. Brain Research: Brain Research Reviews. 20:1995;128-154.
39. Post R.M., DeLisi L.E., Holcomb H.H., Uhde T.W., Cohen R., Buchsbaum M.S. Glucose utilization in the temporal cortex of affectively ill patients: positron emission tomography. Biological Psychiatry. 22:1987;545-553.
40. Press W.H., Flannery B.P., Teukolsky S.A., Vetterling W.T. Numerical Recipes. 1986;Cambridge University Press, New York.
41. Rajkowska G., Goldman-Rakic P.S. Cytoarchitectonic definition of prefrontal areas in the normal human cortex: II. Variability in locations of areas 9 and 46 and relationship to the Talairach coordinate system. Cerebral Cortex. 5:1995;323-337.
42. Rubin E., Sackeim H.A., Nobler M.S., Moeller J.R. Brain imaging studies of antidepressant treatment. Psychiatric Annals. 24:1994;653-658.
43. Spitzer R.L., Endicott J. Schedule for Affective Disorders and Schizophrenia. 1978;New York State Psychiatric Institute, New York, NY.
44. Steinmetz H., Seitz R.J. Functional anatomy of language processing: neuroimaging and the problem of individual variability. Neuropsychologia. 29:1991;1149-1161.
45. Talairach J., Tournoux P. Co-planar Stereotaxic Atlas of the Human Brain. 1988;Thieme, New York, NY.
46. Uytdenhoef P., Portelange P., Jacquy J., Charles G., Linkowski P., Mendlewicz J. Regional cerebral blood flow and lateralized hemispheric dysfunction in depression. British Journal of Psychiatry. 143:1983;128-132.
47. Wheatley D.P., van Moffaert M., Timmerman L., Kremer C.M. and the Mirtazapine-Fluoxetine Study Group. Mirtazapine: efficacy and tolerability in comparison with fluoxetine in patients with moderate to severe major depressive disorder. Journal of Clinical Psychiatry. 59:1998;306-312.